Looks like none of my year-end AMBS wishes will come true. However, I think #1 and #3 have a really good shot in 2015. It's still my opinion that Roche makes the most sense in terms of a classic BP partner for MANF RP and RAO, especially if the RAO gets orphan status.

http://www.roche.com/research_and_development...g-what.htm